Cardiol Therapeutics Income Statement (2020-2026) | CRDL

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
1.69M2.06M2.80M3.04M3.46M3.90M4.14M3.05M2.59M1.92M2.97M2.47M1.98M2.75M3.03M2.62M1.97M3.48M1.97M3.61M
Selling, General & Administrative (Quarter)
3.60M6.01M7.59M4.69M3.78M6.23M2.56M2.71M2.11M3.79M2.93M3.77M3.68M7.62M4.12M3.26M3.57M3.92M3.79M3.47M
Restructuring Costs (Quarter)
1.16M
Operating Expenses (Quarter)
6.45M8.07M10.39M7.73M7.24M10.14M6.70M5.76M4.70M5.71M5.90M6.24M5.66M10.37M7.15M5.87M5.54M7.40M5.76M7.08M
Operating Income (Quarter)
-7.73M-7.24M-10.14M-6.70M-5.76M-4.70M-5.71M-5.90M-6.24M-5.66M-10.37M-7.15M-5.54M-7.40M-5.76M
EBIT (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.70M-5.76M-4.70M-5.71M-5.90M-6.24M-5.66M-10.37M-7.15M-5.87M-5.54M-7.40M-5.76M-7.08M
Non-operating items
Non Operating Investment Income (Quarter)
-1.68M0.68M1.32M0.05M-0.64M0.29M1.34M0.51M0.99M-1.12M
Interest & Investment Income (Quarter)
0.02M0.03M0.02M0.06M0.15M0.30M0.43M0.40M0.39M0.38M0.33M0.28M0.22M0.15M0.22M0.17M0.13M0.09M0.13M0.15M
Other Non Operating Income (Quarter)
-0.13M0.10M3.89M-1.08M1.33M2.28M-0.39M0.06M-0.62M0.50M0.20M0.47M0.11M-0.10M-0.29M-0.07M-0.62M0.07M1.31M0.16M
Net income details
EBT (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.27M-5.36M-4.31M-5.33M-5.57M-6.24M-5.44M-10.22M-6.93M-5.87M-5.41M-7.31M-5.63M-7.08M
Profit After Tax (Quarter)
-5.34M-7.87M-4.96M-7.07M-5.09M-6.11M-5.54M-5.24M-5.56M-4.42M-5.61M-6.81M-4.82M-9.33M-5.85M-5.78M-6.03M-7.24M-5.17M-7.89M
Income from Continuing Operations (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.27M-5.36M-4.31M-5.33M-5.57M-6.24M-5.44M-10.22M-6.93M-5.87M-5.41M-7.31M-5.63M-7.08M
Consolidated Net Income (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.27M-5.36M-4.31M-5.33M-5.57M-6.24M-5.44M-10.22M-6.93M-5.87M-5.41M-7.31M-5.63M-7.08M
Income towards Parent Company (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.27M-5.36M-4.31M-5.33M-5.57M-6.24M-5.44M-10.22M-6.93M-5.87M-5.41M-7.31M-5.63M-7.08M
Net Income towards Common Stockholders (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.27M-5.36M-4.31M-5.33M-5.57M-6.24M-5.44M-10.22M-6.93M-5.87M-5.41M-7.31M-5.63M-7.08M
Additional items
EPS (Basic) (Quarter)
-0.16-0.24-0.16-0.15-0.21-0.06-0.11-0.09-0.11-0.05-0.12-0.11-0.20-0.14-0.08M-0.04-0.05-0.04-0.05
EPS (Weighted Average and Diluted) (Quarter)
-0.14-0.12-0.14-0.09
Shares Outstanding (Weighted Average) (Quarter)
32.59M34.29M113.38M48.89M48.58M47.80M108.70M47.41M47.72M48.10M109.09M49.91M50.27M51.20M51.23M69.69129.58M136.14M144.76M155.18M
Shares Outstanding (Diluted Average) (Quarter)
34.29M46.05M47.35M51.23M62.38M
EBITDA (Quarter)
-5.23M-8.07M-7.73M-7.24M-10.14M-6.70M-5.76M-4.70M-5.71M-5.90M-6.24M-5.66M-10.37M-7.15M-5.87M-5.54M-7.40M-5.76M-7.08M